Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer’s disease: a stochastic modelling approach
<p>Abstract</p> <p>Background</p> <p>Alzheimer’s disease (AD) is the most frequently diagnosed neurodegenerative disorder affecting humans, with advanced age being the most prominent risk factor for developing AD. Despite intense research efforts aimed at elucidating th...
Main Authors: | Proctor Carole J, Pienaar Ilse, Elson Joanna L, Kirkwood Thomas BL |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-07-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://www.molecularneurodegeneration.com/content/7/1/32 |
Similar Items
-
Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI
by: O. Elaskalani, et al.
Published: (2018-05-01) -
Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates
by: Nicolas Papadopoulos, et al.
Published: (2022-10-01) -
Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
by: Sanaa Sharari, et al.
Published: (2023-07-01) -
The effects of amyloid beta aggregation on neuronal transcription
by: Jesse St. Jean, et al.
Published: (2023-06-01) -
Interplay between epigallocatechin-3-gallate and ionic strength during amyloid aggregation
by: Mantas Ziaunys, et al.
Published: (2021-10-01)